Richard G. Ghalie
2022
In 2022, Richard G. Ghalie earned a total compensation of $1.2M as Chief Medical Officer at MEI Pharma, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $118,528 |
|---|---|
| Option Awards | $575,200 |
| Salary | $463,000 |
| Total | $1,156,728 |
Ghalie received $575.2K in option awards, accounting for 50% of the total pay in 2022.
Ghalie also received $118.5K in non-equity incentive plan and $463K in salary.
Rankings
In 2022, Richard G. Ghalie's compensation ranked 2,750th out of 5,736 executives tracked by ExecPay. In other words, Ghalie earned more than 52.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,750 out of 5,736 | 52nd |
Division Manufacturing | 1,531 out of 3,125 | 51st |
Major group Chemicals And Allied Products | 709 out of 1,416 | 50th |
Industry group Drugs | 661 out of 1,317 | 50th |
Industry Pharmaceutical Preparations | 477 out of 963 | 51st |
Source: SEC filing on October 27, 2022.
Ghalie's colleagues
We found three more compensation records of executives who worked with Richard G. Ghalie at MEI Pharma in 2022.